LMAT - Chairman and CEO At LeMaitre Vascular Sells $2.79M Of Stock | Benzinga
It was reported on December 11, that George LeMaitre, Chairman and CEO at LeMaitre Vascular (NASDAQ:LMAT) executed a significant insider sell, according to an SEC filing.
What Happened: LeMaitre opted to sell 50,995 shares of LeMaitre Vascular, according to a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The transaction's total worth stands at $2,785,266.
As of Tuesday morning, LeMaitre Vascular shares are down by 0.0%, currently priced at $54.4.
About LeMaitre Vascular
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
LeMaitre Vascular's Financial Performance
Revenue Growth: LeMaitre Vascular's remarkable performance in 3 months is evident. As of 30 September, 2023, the company achieved an impressive revenue growth rate of 21.48%. ...